Rejected at 2:45 a.m. Nov, 01, 2023 ] by Aaron
Author: CTE_BrainDamage
Related Note: 1484966181191
Rationale for change

@Aaron resolved their suggestion to this card with improper sourcing and unresolved discussion in its comments; I do appreciate dating UTD notes, this should be done more often.

Original card was clearly referencing performance-only SAD, though poorly worded. Changing this card eliminates Performance-only SAD from the Step 1 deck entirely; I do not see reason to do so rather than just wording it better.
Also, AMBOSS does not list benzodiazepines as a treatment option for SAD specifically for anxiety-inducing situations, rather it is second line if SSRI/SNRI fails and there is negative history of SUD. This should be added as a note in the extra of nid:1484966178952 instead as this is a lower yield card in the first place. I've submitted a suggestion there as an example.

AMBOSS source: https://next.amboss.com/us/article/kP0mUT?q=social+anxiety+disorder#Z066f13da3fd48056279c5ad777dac1bc
"Pharmacotherapy for performance-only SAD: beta blockers (e.g., propranolol) OR benzodiazepines (e.g., clonazepam)
Given on an as-needed basis
Taken 30–60 minutes before an anxiety-causing event"

FA2023 pg 582 (Matches FA image in that field)

Rejection reason

Accepting other suggestion. Credit to you for finding the issue. Thanks.

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy
Empty field
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
OME

Additional Resources
One by one
Empty field
#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Psychiatry_/_Psychology #AK_Step2_v12::#NBME #AK_Step1_v12::#OME_banner::Clinical::12_Psychiatry::01_Anxiety_Disorders #AK_Step1_v12::^Other::^FA_Updates::FA2018 #AK_Step2_v12::#Subjects::Psychiatry::01_Anxiety_Disorders::Social_Anxiety_Disorder::Management #AK_Step1_v12::^Other::^EXPN::BGedit #AK_Step2_v12::#Resources_by_rotation::Psych::uworld::zanki #AK_Step2_v12::!Shelf::Psych::no_dupes #AK_Step2_v12::#UWorld::2502 #AK_Step1_v12::#FirstAid::13_Psychiatry::02_Pathology::23_Phobias::Social_Anxiety #AK_Step2_v12::Original_decks::Zanki_Step_2::Psych::UW_Psych #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step2_v12::#Resources_by_rotation::IM::amboss_medicalark #AK_Step1_v12::^Other::^HighYield::4-LowerYield #AK_Step1_v12::#Physeo::07_Psychiatry::02_Psychiatry::06_Anxiety_Disorders #AK_Step1_v12::#Bootcamp::Psychiatry::04_Anxiety_Trauma_and_Stress_Disorders::02_Phobias #AK_Step1_v12::#Bootcamp::Psychiatry::08_Substance_Misuse::05_Benzodiazepines !AK_UpdateTags::^temporary::ImageFix::Table #AK_Step2_v12::#Subjects::Psychiatry::01_Anxiety_Disorders::Social_Anxiety_Disorder #AK_Step2_v12::#AMBOSS #AK_Step2_v12::#B&B::13_Psychiatry::02_Psychiatric_disorders::03_Anxiety_Disorders #AK_Step1_v12::^Systems::Psychiatry #AK_Step1_v12::#B&B::17_Psych::02_Pathology::11_Anxiety_Disorders #AK_Step2_v12::!Shelf::IM::no_dupes::only_step2 #AK_Step2_v12::#AMBOSS::PSYCH #AK_Step1_v12::#UWorld::11756 !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Psychiatry-/-Psychology